September 26, 2024 09:00 PM EDT
Startups
Special

End­points 11 win­ner Car­du­ri­on Phar­ma­ceu­ti­cals: A shot at one of heart dis­ease’s 'un­drug­gable' tar­gets

Lei Lei Wu

News Reporter

↑
  • CEO Pe­ter Lawrence
  • To­tal raised More than $500 mil­lion
  • Head­quar­ters Burling­ton, MA

‘Un­drug­gable’ tar­gets aren’t just in on­col­o­gy. Car­du­ri­on Phar­ma­ceu­ti­cals …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times